BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26236481)

  • 1. NOSH-aspirin (NBS-1120), a dual nitric oxide and hydrogen sulfide-releasing hybrid, reduces inflammatory pain.
    Fonseca MD; Cunha FQ; Kashfi K; Cunha TM
    Pharmacol Res Perspect; 2015 Jun; 3(3):e00133. PubMed ID: 26236481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid is a potent inhibitor of colon cancer cell growth in vitro and in a xenograft mouse model.
    Chattopadhyay M; Kodela R; Olson KR; Kashfi K
    Biochem Biophys Res Commun; 2012 Mar; 419(3):523-8. PubMed ID: 22366248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NOSH-sulindac (AVT-18A) is a novel nitric oxide- and hydrogen sulfide-releasing hybrid that is gastrointestinal safe and has potent anti-inflammatory, analgesic, antipyretic, anti-platelet, and anti-cancer properties.
    Kashfi K; Chattopadhyay M; Kodela R
    Redox Biol; 2015 Dec; 6():287-296. PubMed ID: 26298203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid has enhanced chemo-preventive properties compared to aspirin, is gastrointestinal safe with all the classic therapeutic indications.
    Kodela R; Chattopadhyay M; Velázquez-Martínez CA; Kashfi K
    Biochem Pharmacol; 2015 Dec; 98(4):564-72. PubMed ID: 26394025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NOSH-aspirin (NBS-1120), a novel nitric oxide and hydrogen sulfide releasing hybrid, attenuates neuroinflammation induced by microglial and astrocytic activation: a new candidate for treatment of neurodegenerative disorders.
    Lee M; McGeer E; Kodela R; Kashfi K; McGeer PL
    Glia; 2013 Oct; 61(10):1724-34. PubMed ID: 23918470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and anti-cancer potential of the positional isomers of NOSH-aspirin (NBS-1120) a dual nitric oxide and hydrogen sulfide releasing hybrid.
    Vannini F; MacKessack-Leitch AC; Eschbach EK; Chattopadhyay M; Kodela R; Kashfi K
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4677-82. PubMed ID: 26323873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility Of Nitric Oxide And Hydrogen Sulfide-Releasing Chimeras As Anticancer Agents.
    Kashfi K
    Redox Biol; 2015 Aug; 5():420. PubMed ID: 28162289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NOSH-Aspirin: A Novel Nitric Oxide-Hydrogen Sulfide-Releasing Hybrid: A New Class of Anti-inflammatory Pharmaceuticals.
    Kodela R; Chattopadhyay M; Kashfi K
    ACS Med Chem Lett; 2012 Mar; 3(3):257-262. PubMed ID: 22916316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positional isomerism markedly affects the growth inhibition of colon cancer cells by NOSH-aspirin: COX inhibition and modeling.
    Vannini F; Chattopadhyay M; Kodela R; Rao PPN; Kashfi K
    Redox Biol; 2015 Dec; 6():318-325. PubMed ID: 26319435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the Potential of Nitric Oxide and Hydrogen Sulfide (NOSH)-Releasing Synthetic Compounds as Novel Priming Agents against Drought Stress in
    Antoniou C; Xenofontos R; Chatzimichail G; Christou A; Kashfi K; Fotopoulos V
    Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31936819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NOSH-aspirin (NBS-1120) inhibits pancreatic cancer cell growth in a xenograft mouse model: Modulation of FoxM1, p53, NF-κB, iNOS, caspase-3 and ROS.
    Chattopadhyay M; Kodela R; Santiago G; Le TTC; Nath N; Kashfi K
    Biochem Pharmacol; 2020 Jun; 176():113857. PubMed ID: 32061771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kaurenoic acid from Sphagneticola trilobata Inhibits Inflammatory Pain: effect on cytokine production and activation of the NO-cyclic GMP-protein kinase G-ATP-sensitive potassium channel signaling pathway.
    Mizokami SS; Arakawa NS; Ambrosio SR; Zarpelon AC; Casagrande R; Cunha TM; Ferreira SH; Cunha FQ; Verri WA
    J Nat Prod; 2012 May; 75(5):896-904. PubMed ID: 22574649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrointestinal safety, chemotherapeutic potential, and classic pharmacological profile of NOSH-naproxen (AVT-219) a dual NO- and H2S-releasing hybrid.
    Chattopadhyay M; Kodela R; Duvalsaint PL; Kashfi K
    Pharmacol Res Perspect; 2016 Apr; 4(2):e00224. PubMed ID: 27069635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NOSH-Aspirin Inhibits Colon Cancer Cell Growth: Effects Of Positional Isomerism.
    Vannini F; Kodela R; Chattopadhyay M; Kashfi K
    Redox Biol; 2015 Aug; 5():421. PubMed ID: 28162291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antinociceptive activities of the methanol extract of the bulbs of Dioscorea bulbifera L. var sativa in mice is dependent of NO-cGMP-ATP-sensitive-K(+) channel activation.
    Nguelefack TB; Dutra RC; Paszcuk AF; Andrade EL; Tapondjou LA; Calixto JB
    J Ethnopharmacol; 2010 Apr; 128(3):567-74. PubMed ID: 20152893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitexin inhibits inflammatory pain in mice by targeting TRPV1, oxidative stress, and cytokines.
    Borghi SM; Carvalho TT; Staurengo-Ferrari L; Hohmann MS; Pinge-Filho P; Casagrande R; Verri WA
    J Nat Prod; 2013 Jun; 76(6):1141-9. PubMed ID: 23742617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pimaradienoic acid inhibits inflammatory pain: inhibition of NF-κB activation and cytokine production and activation of the NO-cyclic GMP-protein kinase G-ATP-sensitive potassium channel signaling pathway.
    Possebon MI; Mizokami SS; Carvalho TT; Zarpelon AC; Hohmann MS; Staurengo-Ferrari L; Ferraz CR; Hayashida TH; de Souza AR; Ambrosio SR; Arakawa NS; Casagrande R; Verri WA
    J Nat Prod; 2014 Nov; 77(11):2488-96. PubMed ID: 25394199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological activity of NOSH-naproxen (AVT-219) and NOSH-sulindac (AVT-18A) as potent anti-inflammatory agents with chemotherapeutic potential.
    Kodela R; Chattopadhyay M; Kashfi K
    Medchemcomm; 2013; 4(11):. PubMed ID: 24273639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical anti-inflammatory and analgesic activities of standardized pomegranate rind extract in comparison with its marker compound ellagic acid in vivo.
    Mo J; Panichayupakaranant P; Kaewnopparat N; Nitiruangjaras A; Reanmongkol W
    J Ethnopharmacol; 2013 Jul; 148(3):901-8. PubMed ID: 23743057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tephrosia sinapou ethyl acetate extract inhibits inflammatory pain in mice: opioid receptor dependent inhibition of TNFα and IL-1β production.
    Martinez RM; Zarpelon AC; Cardoso RD; Vicentini FT; Georgetti SR; Baracat MM; Andrei CC; Moreira IC; Verri WA; Casagrande R
    Pharm Biol; 2013 Oct; 51(10):1262-71. PubMed ID: 23855752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.